Jamie L. Reynoso sold $57k of CLOV
CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE. 21,801 shares at an average of $2.60, traded Jul 3, 2025, filed Jul 8, 2025.
Score components
- +25RoleCEO
- +7Trade size$57k at market
- 0Share of holdings soldSold 0.7% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -27.5%, 3m -11.5%, 6m -15.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001801170-25-000168, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 3, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -19,789 | $2.58 | $51k | 3,308,539 | Jul 8, 2025 |
| Jul 3, 2025 | FTax withholding Class A Common Stock10b5-1 | -8,706 | $2.56 | $22k | 3,299,833 | Jul 8, 2025 |
| Jul 7, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,012 | $2.85 | $5,734 | 3,297,821 | Jul 8, 2025 |
Related signals
Other insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $9,288 2,006 shares | -0% | |
| 19Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $39k 8,750 shares | -0% | |
| 38Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Andrew Toy Chief Executive Officer | $1.3M 318,806 shares | -3% | |
| 20Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $8,760 1,921 shares | -0% | |
| 10Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | $15k 3,170 shares | -1% | |
| 50Moderate | CLOVER HEALTH INVESTMENTS, CORP. /DE | Conrad Wai CEO, Counterpart Health | $1.4M 300,000 shares | -20% | |
| 26Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jamie L. Reynoso CEO, Medicare Advantage | $44k 9,273 shares | -0% | |
| 16Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Karen Soares Chief Legal Officer | $33k 6,846 shares | -0% | |
| 40Moderate | CLOVER HEALTH INVESTMENTS, CORP. /DE | Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | $103k 20,000 shares | -7% | |
| 19Weak | CLOVER HEALTH INVESTMENTS, CORP. /DE | Joseph Clay Thornton Interim CFO | $78k 17,775 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.